Wharton Club Of DC

November 3, 2017 12:30 PM

Location: Ballroom

Dr. Scott Gottlieb, the commissioner of the Food and Drug Administration, will appear at a National Press Club Headliners Luncheon on Friday, Nov. 3 to discuss the FDA’s agenda and related issues.

Gottlieb was scheduled for a Sept. 29 Luncheon, which had to be postponed. As a result of the impact of Hurricane Maria on Puerto Rico and the large number of pharmaceutical and medical device manufacturing facilities on the island he had to travel to Puerto Rico on the original date of his Headliners Luncheon to meet with industry executives and government officials to assess the impact the hurricane had on the U.S. drug supply.

Dr. Gottlieb was sworn in as the 23rd FDA commissioner on May 10th. Since taking office, he has focused on:

• increasing efficiency and consistency in the review process,
• addressing the opioid crisis,
• growing competition as a mechanism to make pharmaceuticals more accessible, and
• addressing the chronic staff shortage.
• Meet Dr. Gottlieb:

Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA's Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner.

• He also worked on implementation of the Medicare drug benefit as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.
• In 2013 Dr. Gottlieb was appointed by the Senate to serve on the Federal Health Information Technology Policy Committee, which advises the Department of Health and Human Services on healthcare information technology.
• Dr. Gottlieb was previously a Resident Fellow at the American Enterprise Institute, and a Clinical Assistant Professor at the New York University School of Medicine in Manhattan, where he also practiced medicine as a hospitalist physician.
• He completed a residency in internal medicine at the Mount Sinai Medical Center in New York, New York and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University, in Middletown, Connecticut, where he studied Economics.